Compare GLAS & PWRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLAS | PWRL |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.2M | 475.2M |
| IPO Year | 2021 | 2025 |
| Metric | GLAS | PWRL |
|---|---|---|
| Price | $4.08 | $12.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 182.5K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.49 | N/A |
| Revenue Next Year | $27.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.15 | $9.41 |
| 52 Week High | $12.70 | $16.31 |
| Indicator | GLAS | PWRL |
|---|---|---|
| Relative Strength Index (RSI) | 12.55 | 60.52 |
| Support Level | N/A | $10.36 |
| Resistance Level | $10.53 | $12.57 |
| Average True Range (ATR) | 0.52 | 0.56 |
| MACD | -0.18 | 0.11 |
| Stochastic Oscillator | 4.23 | 72.42 |
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
Powerlaw Corp is a non-diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation. It seeks to achieve its investment objective by investing in the equity and equity-linked securities of a concentrated portfolio of approximately 12 to 15 late-stage technology companies.